Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300077545Phase 4Not yet recruiting
Phase 4, open-label trial of remimazolam and propofol in Lithiasis (2 arms), sponsored by Second Affiliated Hospital of Kunming Medical University. Primary endpoints: mean blood pressure, heart rate and 4 more. Planned start Nov 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300077545.